About this EventAdd to calendar
Presented by: Mark Walters, MD
Jordan Family Director, Blood & Marrow Transplant Program, BCH Oakland
Interim Chief, Hematology Division Professor, Pediatrics/Hematology
UCSF Benioff Children's Hospital Oakland
1. Examine the current results of allogeneic HCT (hematopoietic cell transplantation) for sickle cell disease and recipient/donor features that affect outcomes.
2. Differentiate the types of gene and genomic therapy approaches in sickle cell disease.
3. Compare the benefits vs. safety risks associated with gene therapies for sickle cell disease.
UCSF Benioff Children’s Hospital Oakland is accredited by the California Medical Association to provide continuing medical education for physicians.
UCSF Benioff Children’s Hospital Oakland designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For CME credit, online evaluations must be completed by 12pm on the Friday after Grand Rounds. Requests for the link to the current evaluation must be sent to Cristina.Fernandez@ucsf.edu by NOON on the day of Grand Rounds.